Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine

SIMPLE SUMMARY: Immune-oncology has revolutionized the natural history of many cancers in the past decade, becoming a new therapeutic weapon. The identification of immune “checkpoints” (PD-1/CTLA-4) whose blockade stimulates anti-tumor immunity has changed outcomes for many ptients. However, immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Longhitano, Elisa, Muscolino, Paola, Lo Re, Claudia, Ferrara, Serena Ausilia, Cernaro, Valeria, Gembillo, Guido, Tessitore, Dalila, Speranza, Desirèe, Figura, Francesco, Santarpia, Mariacarmela, Silvestris, Nicola, Santoro, Domenico, Franchina, Tindara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046877/
https://www.ncbi.nlm.nih.gov/pubmed/36980777
http://dx.doi.org/10.3390/cancers15061891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046877/
https://www.ncbi.nlm.nih.gov/pubmed/36980777
http://dx.doi.org/10.3390/cancers15061891

Ejemplares similares